Literature DB >> 28766199

A Patient-Specific 3D-Printed Form Accurately Transfers Supine MRI-Derived Tumor Localization Information to Guide Breast-Conserving Surgery.

Richard J Barth1, Venkataramanan Krishnaswamy2, Keith D Paulsen2, Timothy B Rooney3, Wendy A Wells4, Elizabeth Rizzo4, Christina V Angeles5, Jonathan D Marotti4, Rebecca A Zuurbier3, Candice C Black4.   

Abstract

BACKGROUND: Wire-localized excision of nonpalpable breast cancer is imprecise, resulting in positive margins 25-30% of the time.
METHODS: Patients underwent preoperative supine magnetic resonance imaging (MRI). A radiologist outlined the tumor edges on consecutive images, creating a three-dimensional (3D) view of its location. Using 3D printing, a bra-like plastic form (the Breast Cancer Locator [BCL]) was fabricated, with features that allowed a surgeon to (1) mark the edges of the tumor on the breast surface; (2) inject blue dye into the breast 1 cm from the tumor edges; and (3) place a wire in the tumor at the time of surgery.
RESULTS: Nineteen patients with palpable cancers underwent partial mastectomy after placement of surgical cues using patient-specific BCLs. The cues were in place in <5 min and no adverse events occurred. The BCL accurately localized 18/19 cancers. In the 18 accurately localized cases, all 68 blue-dye injections were outside of the tumor edges. Median distance from the blue-dye center to the pathologic tumor edge was 1.4 cm, while distance from the blue dye to the tumor edge was <5 mm in 4% of injections, 0.5-2.0 cm in 72% of injections, and >2 cm in 24% of injections. Median distance from the tumor center to the BCL-localized wire and to the clip placed at the time of diagnosis was similar (0.49 vs. 0.73 cm) on specimen mammograms.
CONCLUSIONS: Information on breast cancer location and shape derived from a supine MRI can be transferred safely and accurately to patients in the operating room using a 3D-printed form.

Entities:  

Mesh:

Year:  2017        PMID: 28766199      PMCID: PMC6015768          DOI: 10.1245/s10434-017-5979-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  19 in total

1.  Margin re-excision and local recurrence in invasive breast cancer: A cost analysis using a decision tree model.

Authors:  Shoko E Abe; Joshua S Hill; Yimei Han; Kendall Walsh; James T Symanowski; Lejla Hadzikadic-Gusic; Teresa Flippo-Morton; Terry Sarantou; Meghan Forster; Richard L White
Journal:  J Surg Oncol       Date:  2015-09-16       Impact factor: 3.454

2.  Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy.

Authors:  Richard J Barth; Glen R Gibson; Patricia A Carney; Leila A Mott; Robert D Becher; Steven P Poplack
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

3.  Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging.

Authors:  Jennifer H Menell; Elizabeth A Morris; D David Dershaw; Andrea F Abramson; Edi Brogi; Laura Liberman
Journal:  Breast J       Date:  2005 Nov-Dec       Impact factor: 2.431

4.  Do reexcisions impair aesthetic outcome in breast conservation surgery? Exploratory analysis of a prospective cohort study.

Authors:  Joerg Heil; Kathrin Breitkreuz; Michael Golatta; Elena Czink; Julia Dahlkamp; Joachim Rom; Florian Schuetz; Maria Blumenstein; Geraldine Rauch; Christof Sohn
Journal:  Ann Surg Oncol       Date:  2011-07-15       Impact factor: 5.344

5.  MRI-guided quadrantectomy in patients with ductal carcinoma in situ detected preoperatively by mammographic calcifications.

Authors:  Masahiro Sakakibara; Jissei Yokomizo; Nobumitsu Shiina; Toshiki Kazama; Rikiya Nakamura; Hiroshi Fujimoto; Takeshi Nagashima; Hazuki Takishima; Yukio Nakatani; Masaru Miyazaki
Journal:  J Am Coll Surg       Date:  2014-03-18       Impact factor: 6.113

6.  Supine breast MRI and 3D optical scanning: a novel approach to improve tumor localization for breast conserving surgery.

Authors:  Matthew J Pallone; Steven P Poplack; Hima Bindu R Avutu; Keith D Paulsen; Richard J Barth
Journal:  Ann Surg Oncol       Date:  2014-03-12       Impact factor: 5.344

7.  Intraoperative ultrasound is associated with clear lumpectomy margins for palpable infiltrating ductal breast cancer.

Authors:  M M Moore; L A Whitney; L Cerilli; J Z Imbrie; M Bunch; V B Simpson; J B Hanks
Journal:  Ann Surg       Date:  2001-06       Impact factor: 12.969

8.  A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer.

Authors:  Anees B Chagpar; Brigid K Killelea; Theodore N Tsangaris; Meghan Butler; Karen Stavris; Fangyong Li; Xiaopan Yao; Veerle Bossuyt; Malini Harigopal; Donald R Lannin; Lajos Pusztai; Nina R Horowitz
Journal:  N Engl J Med       Date:  2015-05-30       Impact factor: 91.245

9.  Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.

Authors:  Wendie A Berg; Lorena Gutierrez; Moriel S NessAiver; W Bradford Carter; Mythreyi Bhargavan; Rebecca S Lewis; Olga B Ioffe
Journal:  Radiology       Date:  2004-10-14       Impact factor: 11.105

10.  Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent.

Authors:  C Boetes; R D Mus; R Holland; J O Barentsz; S P Strijk; T Wobbes; J H Hendriks; S H Ruys
Journal:  Radiology       Date:  1995-12       Impact factor: 11.105

View more
  2 in total

1.  The shape of breast cancer.

Authors:  Brook K Byrd; Venkataramanan Krishnaswamy; Jiang Gui; Timothy Rooney; Rebecca Zuurbier; Kari Rosenkranz; Keith Paulsen; Richard J Barth
Journal:  Breast Cancer Res Treat       Date:  2020-07-12       Impact factor: 4.872

2.  Breast-conserving surgery with 3D-printed surgical guide: a single-center, prospective clinical study.

Authors:  Zhen-Yu Wu; Hee Jeong Kim; Jongwon Lee; Il Yong Chung; Jisun Kim; Saebyeol Lee; Byung Ho Son; Sei-Hyun Ahn; Hak Hee Kim; Joon Beom Seo; Jae Ho Jeong; Gyungyub Gong; Namkug Kim; BeomSeok Ko
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.